Skip to main content

Table 3 Comparison of resistance rates among E. coli in Austria between ECO·SENS and ECO·SENS II and contrasting these data with the E. coli resistance data in the Austrian resistance report 2008 for the ambulatory sector

From: Antibacterial resistances in uncomplicated urinary tract infections in women: ECO·SENS II data from primary health care in Austria

Antibiotic Resistance rates Resistance rates Trend between ECO·SENS and ECO·SENS II E. coliresistance data in the Austria resistance report 2008 for the ambulatory sector, n (%)
  ECO·SENS ECO·SENS II   
  (N = 126), n (%) (N = 146), n (%)   
Mecillinam 2 (1.6) 0 (0.0) 4,361 (12.2)
Ampicillin 22 (17.5) 42 (28.8) 8,992 (39.8)
Amoxicillin/clavulanic acid 3 (2.4) 13 (8.9) 8,985 (5.8)
Trimethoprim 12 (9.5) 23 (15.8) -
Sulphamethoxazole 32 (25.4) 31 (21.3) -
Trimethoprim/Sulphamethoxazole 12 (9.5) 21 (14.4) 8,992 (24.6)
Nalidixic acid 3 (2.4) 14 (9.6) -
Nitrofurantoin 1 (0.8) 1 (0.7) 8,789 (2.2)
Ciprofloxacin 0 (0.0) 6 (4.1) 8,992 (15.7)
Gentamicin 1 (0.8) 2 (1.4) 8,990 (4.7)
Fosfomycin trometamol 0 (0) 1 (0.7) 5,489 (1.5)
Cefadroxil 1 (0.8) 6 (4.1)   9,088 (8.5)
Cefotaxime Not tested 4 (2.7)   -
Ceftazidime Not tested 4 (2.7)   -